To confirm this regulation experimentally, we treated HCT116 colon carcinoma cells, both wild-type (WT) and p21 knockout (p21−/−), with Nutlin-3a, a compound that stabilizes and activates p53 by inhibiting MDM2 [39]. The gene discussed is CDKN1A; the disease is colon carcinoma.